Minori Enomoto
Overview
Explore the profile of Minori Enomoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enomoto M, Eto T, Kitamura S
Sleep Biol Rhythms
. 2024 Sep;
22(4):523-529.
PMID: 39300982
This study aimed to investigate the occurrence and age-related changes of the first night effect (FNE) in school-age children using both macro (sleep architecture) and micro (frequency analysis) structures to...
2.
Takeshima M, Yoshizawa K, Enomoto M, Ogasawara M, Kudo M, Itoh Y, et al.
Psychiatry Clin Neurosci
. 2022 Dec;
77(5):264-272.
PMID: 36579672
Aim: The current study aimed to examine the effect of Japanese policies for appropriate hypnotics use and novel hypnotics (e.g. melatonin receptor agonist and orexin receptor antagonist [ORA]) on long-term...
3.
Enomoto M, Kitamura S, Nakazaki K
J Physiol Anthropol
. 2022 Aug;
41(1):29.
PMID: 35982481
Background: Actigraphy is a method used for determining sleep (S)/wakefulness (W) by actigraph, a device equipped with a built-in accelerometer and an algorithm validated for each device. The S/W determination...
4.
Takeshima M, Enomoto M, Ogasawara M, Kudo M, Itoh Y, Yoshizawa K, et al.
Psychiatry Clin Neurosci
. 2022 Jun;
76(9):475-477.
PMID: 35655425
No abstract available.
5.
Inada K, Enomoto M, Yamato K, Mishima K
Drugs Real World Outcomes
. 2021 Mar;
8(3):277-288.
PMID: 33713330
Background: Prolonged treatment of insomnia using benzodiazepine (BZD) receptor agonists, including BZD and non-BZD hypnotic drugs, can cause drug dependence, tolerance, abuse and other adverse events. These side effects are...
6.
Ishizuya A, Enomoto M, Tachimori H, Takahashi H, Sugihara G, Kitamura S, et al.
Sci Rep
. 2021 Jan;
11(1):1707.
PMID: 33462331
Poor adherence is a major concern in the treatment of attention-deficit/hyperactivity disorder (ADHD). The objective of this study was to evaluate factors linked to early interruption of and low adherence...
7.
Yamato K, Inada K, Enomoto M, Marumoto T, Takeshima M, Mishima K
BMC Psychiatry
. 2021 Jan;
21(1):40.
PMID: 33441086
Background: Major depressive disorder (MDD) is highly prevalent in Japan and frequently accompanied by insomnia that may persist even with MDD remission. Hypnotics are used for the pharmacological treatment of...
8.
Inada K, Enomoto M, Yamato K, Marumoto T, Takeshima M, Mishima K
J Affect Disord
. 2021 Jan;
281:539-546.
PMID: 33401142
Background: Residual insomnia is associated with a risk of depression recurrence. Methods: In this retrospective, longitudinal cohort study, the recurrence pattern of depression in patients with or without residual insomnia...
9.
Yamamoto M, Inada K, Enomoto M, Habukawa M, Hirose T, Inoue Y, et al.
Neuropsychopharmacol Rep
. 2020 Dec;
41(1):14-25.
PMID: 33259705
Aims: Benzodiazepine receptor agonists (BZ-RAs) are frequently prescribed to treat insomnia; however, their long-term use is not recommended. To introduce an appropriate pharmaco-therapy, the current state and background factors of...
10.
Kayaba M, Matsushita T, Enomoto M, Kanai C, Katayama N, Inoue Y, et al.
BMC Public Health
. 2020 Mar;
20(1):371.
PMID: 32197650
Background: The aims of this study were 1) to clarify the prevalence of sleep problems (insomnia, insufficient sleep, and delayed sleep-wake phase) among Japanese university students; 2) to examine sociodemographic...